Los Alamos National Laboratory researchers are espousing the benefits of a new artificial intelligence (AI) tool capable of identifying COVID-19-related conspiracy theories on social media.
The AI models how the conspiracy theories evolved and how they could someday help public health officials... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently awarded contracts to FLIR Systems, Leidos, and Charles River Analytics to create lightweight materials and more adaptable countermeasures for equipment protective against chemical and biological threats.
The problem is, while... Read More »
Several over-the-counter drugs could potentially find new lives treating COVID-19 symptoms, as the National Institutes of Health (NIH) announced this week that $155 million would be invested into a phase three trial of up to seven self-administered medications to that end.
It will be a... Read More »
The U.S. Food and Drug Administration (FDA) revoked last week the emergency use authorization (EUA) for the sole use of the monoclonal antibody therapy bamlanivimab against COVID-19.
“Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2... Read More »
A new report by the World Health Organization (WHO) shows that there remains a relative dearth of antibacterial treatments in the pipeline, despite the growing threat of antibiotic resistance.
The WHOʻs annual Antibacterial Pipeline Report found that of the 43 antibiotics that are currently in... Read More »
To provide real-time updates on federal actions that could help defend against biological threats, the Bipartisan Commission on Biodefense has created an interactive recommendations tracker of completed, in-progress, and items of inaction.
“This new and interactive tracker will build on the... Read More »
Amid rising fears that variants of COVID-19 may already be reducing the efficacy of vaccines, INOVIO provided some good news last week, with news that its vaccine candidate produced neutralizing antibodies and T cell responses against all three major variant strains.
INO-4800, a DNA vaccine... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) will invest approximately $24 million into the first year of contracts for the Centers of Excellence for Influenza Research and Response (CEIRR) to aid a network of research sites investigating influenza.
These institutions cover... Read More »
Department of Homeland Security Cybersecurity and Infrastructure Security Agency (CISA) personnel and partners are espousing the benefits of a recently executed tabletop exercise designed to bolster Indianapolis 500 race safety.
CISA joined Indianapolis Motor Speedway officials, state and local... Read More »
The University of Maryland, Baltimore County (UMBC) has utilized the BioFlash Biological Identifier created by Smiths Detection to successfully identify airborne traces of SARS-CoV-2 inside its campus in real-time.
BioFlash is a device that collects and analyses air samples, rapidly sifting... Read More »
National Institute of Standards and Technology (NIST) engineers are espousing the benefits of a low-cost computer system connecting older public safety radios with the latest wireless communications networks.
“This NIST project aims to develop a prototype infrastructure that could be used by... Read More »
FLIR Systems, Inc. announced Monday that it had won a contract with the Defense Advanced Research Projects Agency (DARPA) to develop new fabrics embedded with catalysts and chemical agents that can fight and reduce chemical and biological threats on contact.
The fabrics will be incorporated... Read More »
Specialty vaccine company Valneva SE has concluded recruitment of 4,131 adults for a phase three trial of VLA1553, a single-shot chikungunya vaccine candidate.
If approved, VLA1553 would be the first chikungunya vaccine to gain Biologics License Application. This would, in turn, earn its... Read More »
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) said its partnership with Niceville, Florida-based DEFENSEWERX (DWX) would bolster Homeland Security solutions advancement efforts.
DWX is a nonprofit organization focusing on cultivating ecosystems enabling... Read More »
A mix of casirivimab and imdevimab, Regeneron Pharmaceuticals Inc.'s REGEN-COV, is now strongly recommended by the National Institutes of Health (NIH) for high risk COVID-19 patients that are non-hospitalized.
The drug was given a strong rate based on randomized trials, which involved more than... Read More »
The international COVAX facility has managed to deliver more than 38 million doses of various COVID-19 vaccine manufacturers to more than 100 economies within 42 days of its first international delivery to Ghana on Feb. 24, 2021.
It is a positive start for a massive global undertaking meant to... Read More »
The Centers for Disease Control and Prevention (CDC) has earmarked $3 billion to 64 jurisdictions to bolster broad-based COVID-19 vaccine distribution, access, and administration efforts.
The funding allotment would support local efforts to increase vaccine uptake by expanding COVID-19 vaccine... Read More »
Moderna, Inc. is trumpeting the interim results of a phase three trial of its COVID-19 vaccine, which have shown antibodies persisting for six months post-vaccination.
These results, published in The New England Journal of Medicine, come with some caveats, though. While the results were founded... Read More »
An assessment by the COVID-19 subcommittee of the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety (GACVS) has concluded that blood clots affiliated with the AstraZeneca vaccine are concerning but rare and require further study to determine a causal relationship.
All... Read More »
Bavarian Nordic received a new supply order from Janssen Pharmaceutica NV to manufacture and deliver bulk drug substance of MVA-BN Filo vaccine to treat Ebola.
The MVA-BN Filo vaccine will be licensed to Janssen as part of its Ebola vaccine regimen, Zabdeno and Mvabea, which the European... Read More »
The specialty vaccine company Valneva SE has issued positive data for Part A of the Phase 1/2 clinical trial of its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.
Officials noted subject to regulatory approval, the company plans to initiate a Phase 3 clinical trial by the end of... Read More »
Moderna, Inc. is joining forces with Catalent, Inc. to create a high-speed vial filling line in Indiana that will aid the manufacture of its COVID-19 vaccine and, potentially, other items in Moderna’s clinical portfolio.
While Catalent -- a provider of advanced delivery technologies,... Read More »
The Symbiotica COVID-19 Self-Collected Antibody Test System gained emergency use authorization from the United States Food and Drug Administration (FDA) this week, making it the first antibody test authorized for use with self-collected dried blood spot samples.
The test allows those prescribed... Read More »
A new COVID-19 vaccine developed by the Walter Reed Army Institute of Research (WRAIR) began a phase one clinical trial this week, following positive preclinical showings against SARS-CoV-2, its variants, and SARS-CoV-1, as well.
"Even before recent COVID-19 variants were identified, our team... Read More »
Emergent BioSolutions Inc. reported this week that it is on schedule to meet all manufacturing commitments related to COVID-19 vaccines, and that the Biomedical Advanced Research and Development Authority (BARDA) has increased its original task order by $23 million.
The funding injection from... Read More »
Alion Science and Technology has secured a $77 million Air Force agreement to provide aircraft and weapons systems research and development for the F-35 Lightning II Joint Program Office (JPO).
Officials indicated the task without order possesses a 60-month period of performance via the... Read More »
An ongoing Phase 2a trial of a Janssen Pharmaceutical Companies-developed COVID-19 vaccine candidate has been expanded to include adolescents between the ages of 12 and 17.
While there are still no approved COVID-19 vaccines for children, cases of COVID-19 in children have generally been less... Read More »
Although it already has a successful COVID-19 vaccine in circulation, Moderna is developing a vaccine designed to address the troubling South African variant of the disease (B.1.351), and as of last week, the National Institutes of Health (NIH) began a phase one trial to evaluate it.
Known as... Read More »
Department of Homeland Security Cybersecurity and Infrastructure Security Agency (CISA) personnel recently joined NASCAR and law enforcement officials in a tabletop exercise focusing on GEICO 500 hypothetical public safety incidents.
CISA Executive Assistant Director for Infrastructure Security... Read More »
Bell Textron and Army officials said terms have been reached regarding the execution of the Competitive Demonstration and Risk Reduction (CD&RR) contract's second phase involving the V-280 Valor design.
“This is the next step to a program of record, and Bell is proud to closely collaborate... Read More »
Clinicians have created a portable test -- dubbed NIRVANA -- capable of detecting and sequencing COVID-19, its variants, and other viruses in mere moments, according to data published in the journal Med.
Primarily, the test cuts out the need for extra diagnostics and middlemen.
"This is a... Read More »
The Coalition for Epidemic Preparedness (CEPI) announced this week that it will invest up to $200 million into promising vaccine candidates for SARS-CoV-2 and Betacoronavirus, following a call for proposals.
This funding will carry candidates through to clinical proof of concept and forms one... Read More »
Global healthcare company GSK has reached a principle agreement with Novavax and the UK Government Vaccines Taskforce to support the manufacturing of up to 60 million doses of Novavax’ COVID-19 vaccine.
Under the agreement, GSK will provide manufacturing capacity at its Barnard Castle facility... Read More »
The Navy has awarded BAE Systems a four-year $42.5 million contract to provide shore-based landing systems integration (LSI) support services for instrument carrier and instrument landing systems (ICLS/ILS).
“For several decades, we have been responsible for integrating the Navy’s landing... Read More »
Over the next year, the University of California, Los Angeles (UCLA) will lead a study of COVID-19 vaccine effectiveness on health workers, thanks to a $4.9 million grant from the Centers for Disease Control and Prevention (CDC).
Participants in what is being called the PREVENT (Preventing... Read More »